Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vanda Pharma FDA Panel Live Blog
TheStreet.com
Thursday, November 14, 2013 - 8:53am
tags:
Vanda, FDA, advisory panels, tasimelteon, non-24 hour disorder, blindness
5 FDA-Approved Drugs That Disappointed Investors in 2013
Motley Fool
Wednesday, November 13, 2013 - 10:33pm
tags:
FDA, Amarin, Vivus, Dendreon, Arena Pharmaceuticals, Provenge, Vascepa, Iclusig, Ariad Pharmaceuticals, Belviq, Qsymia
FDA panel supports approval of Sanofi MS drug Lemtrada, with reservations
Yahoo/Reuters
Wednesday, November 13, 2013 - 5:36pm
tags:
FDA, advisory panels, Sanofi, Lemtrada, MS, multiple sclerosis
The Anti-Kickback Statute And The Affordable Care Act: A Law Enforcement Tool Suddenly Goes Missing
Forbes
Wednesday, November 13, 2013 - 12:51pm
tags:
Affordable Care Act, kickbacks, anti-kickback statute, JNJ
Pharmacyclics' Lymphoma Drug Receives FDA Approval
TheStreet.com
Wednesday, November 13, 2013 - 12:50pm
tags:
Pharmacyclics, FDA, Imbruvica, mantle cell lymphoma, ibrutinib
Senate Moves Closer To Passing Pharmacy Compounding Bill
Pharmalot
Wednesday, November 13, 2013 - 12:48pm
tags:
compounding pharmacies
U.S. heart guidelines may threaten hot new cholesterol drugs
Yahoo/Reuters
Wednesday, November 13, 2013 - 12:47pm
tags:
cholesterol, statins, PCSK9 inhibitors, Sanofi, Regeneron, Pfizer, Amgen
Celgene's Revlimid Makes Stronger Case for European Front-Line Approval
TheStreet.com
Wednesday, November 13, 2013 - 11:00am
tags:
Celgene, Revlimid, Europe, Multiple Myeloma
Dendreon Has Another Disaster Quarter
Seeking Alpha
Wednesday, November 13, 2013 - 10:59am
tags:
Dendreon, earnings
5 Private Biotechs Revolutionizing Medicine
Motley Fool
Wednesday, November 13, 2013 - 8:58am
tags:
Alvine Pharmaceuticals, AnaptysBio, CytomX, Parabon Nanolabs, Polyphor
Biopharma Alliances Will Be Needed For Cancer Drugs In The Cost Conscious Future
Forbes
Wednesday, November 13, 2013 - 8:54am
tags:
cancer, biotech, R&D
Cholesterol Guideline Changes Double Number on Treatments
Bloomberg
Wednesday, November 13, 2013 - 8:48am
tags:
cholesterol, statins, AstraZeneca, Merck, Pfizer
[video]Bristol-Myers Squibb's Radical Transformation
Motley Fool
Wednesday, November 13, 2013 - 8:47am
tags:
Bristol-Myers Squibb
Alzheimer’s Clues Sought Studying Link to Down Syndrome
Bloomberg
Wednesday, November 13, 2013 - 8:44am
tags:
Downs Syndrome, JNJ, Alzheimer's disease
Pfizer finally acquires the @pfizer name on Twitter
PM Live
Wednesday, November 13, 2013 - 8:33am
tags:
Pfizer, twitter, social media
Pfizer, Lilly Vs. Rivals In Potential Pain Drug Rivalry
Seeking Alpha
Wednesday, November 13, 2013 - 8:32am
tags:
Pfizer, Eli Lilly, painkillers, tanezumab
Why Big Pharma Is Breaking Up
Motley Fool
Wednesday, November 13, 2013 - 8:29am
tags:
Merck, Novartis, Big Pharma, Abbott Labs, AbbVie, Pfizer, Zoetis
When Should You Take A Statin? The Answer Just Changed.
Forbes
Wednesday, November 13, 2013 - 8:26am
tags:
statins
Discovery Labs Reports Third Quarter 2013 Financial Results
Yahoo
Wednesday, November 13, 2013 - 8:25am
tags:
Discovery Labs, earnings
J&J Said to Reach $4 Billion Deal to Settle Hip Lawsuits
Bloomberg
Tuesday, November 12, 2013 - 4:55pm
tags:
JNJ, hip implants, devices, recalls, DePuy

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.